Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (Jan 2018)
CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume
- Emrah Düzel,
- David Berron,
- Hartmut Schütze,
- Arturo Cardenas‐Blanco,
- Coraline Metzger,
- Matthew Betts,
- Gabriel Ziegler,
- Yi Chen,
- Laura Dobisch,
- Daniel Bittner,
- Wenzel Glanz,
- Martin Reuter,
- Annika Spottke,
- Janna Rudolph,
- Frederic Brosseron,
- Katharina Buerger,
- Daniel Janowitz,
- Klaus Fliessbach,
- Michael Heneka,
- Christoph Laske,
- Martina Buchmann,
- Peter Nestor,
- Oliver Peters,
- Dominik Diesing,
- Siyao Li,
- Josef Priller,
- Eike Jakob Spruth,
- Slawek Altenstein,
- Alfredo Ramirez,
- Anja Schneider,
- Barbara Kofler,
- Oliver Speck,
- Stefan Teipel,
- Ingo Kilimann,
- Martin Dyrba,
- Jens Wiltfang,
- Claudia Bartels,
- Steffen Wolfsgruber,
- Michael Wagner,
- Frank Jessen
Affiliations
- Emrah Düzel
- Institute of Cognitive Neurology and Dementia Research, Otto‐von‐Guericke University MagdeburgMagdeburgGermany
- David Berron
- Institute of Cognitive Neurology and Dementia Research, Otto‐von‐Guericke University MagdeburgMagdeburgGermany
- Hartmut Schütze
- Institute of Cognitive Neurology and Dementia Research, Otto‐von‐Guericke University MagdeburgMagdeburgGermany
- Arturo Cardenas‐Blanco
- Institute of Cognitive Neurology and Dementia Research, Otto‐von‐Guericke University MagdeburgMagdeburgGermany
- Coraline Metzger
- Institute of Cognitive Neurology and Dementia Research, Otto‐von‐Guericke University MagdeburgMagdeburgGermany
- Matthew Betts
- German Center for Neurodegenerative Diseases (DZNE)MagdeburgGermany
- Gabriel Ziegler
- Institute of Cognitive Neurology and Dementia Research, Otto‐von‐Guericke University MagdeburgMagdeburgGermany
- Yi Chen
- Institute of Cognitive Neurology and Dementia Research, Otto‐von‐Guericke University MagdeburgMagdeburgGermany
- Laura Dobisch
- German Center for Neurodegenerative Diseases (DZNE)MagdeburgGermany
- Daniel Bittner
- German Center for Neurodegenerative Diseases (DZNE)MagdeburgGermany
- Wenzel Glanz
- German Center for Neurodegenerative Diseases (DZNE)MagdeburgGermany
- Martin Reuter
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- Annika Spottke
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- Janna Rudolph
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- Frederic Brosseron
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- Katharina Buerger
- German Center for Neurodegenerative Diseases (DZNE)MunichGermany
- Daniel Janowitz
- Institute for Stroke and Dementia Research, University HospitalMunichGermany
- Klaus Fliessbach
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- Michael Heneka
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- Christoph Laske
- German Center for Neurodegenerative Diseases (DZNE)TübingenGermany
- Martina Buchmann
- German Center for Neurodegenerative Diseases (DZNE)TübingenGermany
- Peter Nestor
- German Center for Neurodegenerative Diseases (DZNE)MagdeburgGermany
- Oliver Peters
- German Center for Neurodegenerative Diseases (DZNE)BerlinGermany
- Dominik Diesing
- Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health, Institute of Psychiatry and PsychotherapyBerlinGermany
- Siyao Li
- Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health, Institute of Psychiatry and PsychotherapyBerlinGermany
- Josef Priller
- German Center for Neurodegenerative Diseases (DZNE)BerlinGermany
- Eike Jakob Spruth
- Department of Psychiatry and PsychotherapyBerlinGermany
- Slawek Altenstein
- German Center for Neurodegenerative Diseases (DZNE)BerlinGermany
- Alfredo Ramirez
- Department of PsychiatryUniversity of CologneMedical FacultyCologneGermany
- Anja Schneider
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- Barbara Kofler
- Department of Neurodegeneration and Geriatric PsychiatryUniversity Hospital BonnBonnGermany
- Oliver Speck
- Department of Biomagnetical ResonanceMagdeburgGermany
- Stefan Teipel
- German Center for Neurodegenerative Diseases (DZNE)RostockGermany
- Ingo Kilimann
- German Center for Neurodegenerative Diseases (DZNE)RostockGermany
- Martin Dyrba
- German Center for Neurodegenerative Diseases (DZNE)RostockGermany
- Jens Wiltfang
- German Center for Neurodegenerative Diseases (DZNE)GoettingenGermany
- Claudia Bartels
- German Center for Neurodegenerative Diseases (DZNE)GoettingenGermany
- Steffen Wolfsgruber
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- Michael Wagner
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- Frank Jessen
- German Center for Neurodegenerative Diseases (DZNE)BonnGermany
- DOI
- https://doi.org/10.1016/j.dadm.2018.10.003
- Journal volume & issue
-
Vol. 10,
no. 1
pp. 782 – 790
Abstract
Abstract Introduction We examined the association between cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease, neural novelty responses, and brain volume in predementia old age. Methods We conducted a cross‐sectional analysis of the observational, multicentric DZNE‐Longitudinal Cognitive Impairment and Dementia Study (DELCODE) study. Seventy‐six participants completed task functional magnetic resonance imaging and provided CSF (40 cognitively unimpaired, 21 experiencing subjective cognitive decline, and 15 with mild cognitive impairment). We assessed the correlation between CSF biomarkers and whole‐brain functional magnetic resonance imaging novelty responses to scene images. Results Total tau levels were specifically and negatively associated with novelty responses in the right amygdala and right hippocampus. Mediation analyses showed no evidence that these associations were dependent on the volume of hippocampus/amygdala. No relationship was found between phosphorylated‐tau or Aβ42 levels and novelty responses. Discussion Our data show that CSF levels of total tau are associated with anatomically specific reductions in novelty processing, which cannot be fully explained by atrophy.
Keywords
- Alzheimer's disease (AD)
- Subjective cognitive decline (SCD)
- Mild cognitive impairment (MCI)
- Longitudinal
- Cerebrospinal fluid (CSF)
- Aβ42